Taking these considerations into account, the development of mouse models based on mutations in relevant genes such as amyloid precursor protein (APP) and presenilins 1 and 2 that participate in early-onset familial AD [10] should not be considered as “complete” AD-models. This evidence concerns the gene APP and Alzheimer disease.